510(k) Report

510(k) · Cleared

Cleared

Dryodine Cadexomer-Iodine Gel

K093320510(k) TraditionalCleared Jun 18, 2010238-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Collegium Pharmaceutical Incorporated · FRO Dressing, Wound, Drug

Cleared on Jun 18, 2010 as substantially equivalent to K905069 (Perstorp AB C/O Robert Joel Slomoff, 1991) and 1 other predicate after a 238-day review. Its family tree reaches back 2 generations to 1994.

Decided
Jun 18, 2010
Review
238 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K940414 (1994). 4 ancestors in all, the oldest K905069 (1991). No later device cites it as a predicate yet.

Other ancestors, by year cleared 1991: 1 other ancestor2000: 1 other ancestorK940414 · Iodoflex Paste · Oclassen Pharmaceuticals, Inc. · 1994K051542 · Triosyn T40 Antimicrobial Wound Dressing · Triosyn Corp. · 200619901995200020052010
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor K051542 · Triosyn T40 Antimicrobial Wound Dressing · Triosyn Corp. · 2006K940414 · Iodoflex Paste · Oclassen Pharmaceuticals, Inc. · 19940
  1. Root · 2 generations backK940414 Iodoflex PasteOclassen Pharmaceuticals, Inc. · 1994
  2. 1 generation backK051542 Triosyn T40 Antimicrobial Wound DressingTriosyn Corp. · 2006
  3. This deviceK093320 Dryodine Cadexomer-Iodine GelCollegium Pharmaceutical Incorporated · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K940414Iodoflex PasteOclassen Pharmaceuticals, Inc.1994—
−1K051542Triosyn T40 Antimicrobial Wound DressingTriosyn Corp.2006—
0 (this device)K093320Dryodine Cadexomer-Iodine GelCollegium Pharmaceutical Incorporated2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
200010
FIG. 1 — Lineage of K093320, 1994–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K905069Iodosorb Gel
Summary page 1
…DryodineTm Antibacterial Gel is substantially equivalent to the following predicate devices: - o Iodosorb Gel cleared under 510(k) K905069, from Perstorp Pharmna. o Triosyn T40 Antimicrobial Dressing under 510(k) KO5 1452, from Triosyn Corporation…
Perstorp AB C/O Robert Joel Slomoff1991—
*K051542Triosyn T40 Antimicrobial Wound Dressing
Our reading of the summary gave K051452, FDA’s number for Sentinel Clin Chem Cal (Sentinel Ch. Srl). Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “Triosyn T40 Antimicrobial Dressing”.
Triosyn Corp.2006—

Also cleared against K905069: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 3 companies; a new generation was cleared every 11.9 years on median.
  • None of the 4 ancestors has a recall.
  • 2 other devices also cite its predicate K905069.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

DryodineTM Antibacterial Gel is indicated for use in the management/cleaning of wet ulcers and wounds such as venous stasis ulcers, pressure sores, diabetic foot ulcers, and traumatic and surgical wounds. DryodineTm Antibacterial Gel assists to keep lesions soft and pliable.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093320: Dryodine Cadexomer-Iodine Gel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K093320

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026